Study uncovers novel immune evasion mechanism used by key bacterium in periodontitis

Researchers have identified a new mechanism by which a key bacterium in periodontitis evades the immune system.

RNA editing startup launches with $30M based on Stanford and University of Tübingen research

The race to develop new therapies that precisely edit short-lived RNA molecules instead of making irreversible changes to DNA is heating up. A new entrant

September 20, 2023

UnitedHealthcare CEO Brian Thompson became one of the country’s most powerful insurance execs before tragic killing

MAPLE GROVE, Minn. — Brian Thompson was a mainstay on UnitedHealth Group’s leadership team, working up the ranks over two decades to become one of

December 4, 2024

Zevra Therapeutics completes Acer acquisition in $91m deal

Share this article Acer’s Edsivo is being analysed in Phase III studies for vascular Ehlers-Danlos syndrome. Credit: DC Studio / Shutterstock.com. Zevra Therapeutics has concluded

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.